ArriVent BioPharma, Inc. Quarterly Operating Lease, Liability in USD from Q1 2024 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
ArriVent BioPharma, Inc. quarterly Operating Lease, Liability history and growth rate from Q1 2024 to Q3 2024.
  • ArriVent BioPharma, Inc. Operating Lease, Liability for the quarter ending September 30, 2024 was $213K.
Operating Lease, Liability, Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $213K Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $250K Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $285K Mar 31, 2024 10-Q 2024-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.